Literature DB >> 9628225

Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus.

M R Raabe1, C J Issel, R C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) has been shown to infect cells of monocyte/macrophage lineage. These primary cells are intrinsically difficult to obtain, to purify and to culture in vitro for extended periods of time. As a result, most in vitro studies concerning this lentivirus make use of primary equine fibroblasts or transformed canine or feline cell lines. We describe methods that yield reproducibly pure cultures of equine blood monocytes from peripheral blood mononuclear cells. The in vitro differentiation of these cells into mature equine macrophage was verified using various cytochemical staining methods. The equine monocyte-derived macrophage (MDM) cultures were found to replicate cell-adapted and field strains of EIAV more efficiently than cultures of fully differentiated equine splenic macrophage. Having established reproducible and fully differentiated cultures of equine macrophage, in vitro assays of virus infectivity and serum neutralization were developed using the in vivo target cell of EIAV. These procedures, while developed for the EIAV system, should be equally useful for in vitro cultures of other macrophage-tropic pathogens of horses.

Entities:  

Mesh:

Year:  1998        PMID: 9628225     DOI: 10.1016/s0166-0934(97)00204-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  18 in total

1.  The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

Authors:  F Li; C Leroux; J K Craigo; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Authors:  Jodi K Craigo; Shannon Durkin; Timothy J Sturgeon; Tara Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2006-09-22       Impact factor: 3.641

4.  Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Authors:  C Leroux; J K Craigo; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway.

Authors:  Sha Jin; Baoshan Zhang; Ora A Weisz; Ronald C Montelaro
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.

Authors:  Feng Li; Chaoping Chen; Bridget A Puffer; Ronald C Montelaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro.

Authors:  F Li; B A Puffer; R C Montelaro
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Macrophage effector responses of horses are influenced by expression of CD154.

Authors:  Brett A Sponseller; Sandra K Clark; Jessica Gilbertie; David M Wong; Kate Hepworth; Sarah Wiechert; Prashanth Chandramani; Beatrice T Sponseller; Cody J Alcott; Bryan Bellaire; Andrew C Petersen; Douglas E Jones
Journal:  Vet Immunol Immunopathol       Date:  2016-08-26       Impact factor: 2.046

9.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

10.  Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection.

Authors:  M Julia B F Flaminio; Daryl V Nydam; Hélène Marquis; Mary Beth Matychak; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.